Skip to content

Continuous versus Bolus Norepinephrine for Preventing Nausea and Vomiting during Spinal-Epidural Anesthesia for Cesarean Delivery

Continuous versus Bolus Norepinephrine for Preventing Nausea and Vomiting during Spinal-Epidural Anesthesia for Cesarean Delivery: A Single-Center, Double-Blind, Prospective, Randomized Controlled Trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112628
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-11-18
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Delivery

Interventions

Continuous Norepinephrine group:Prophylactic Intravenous Infusion of Norepinephrine (4 µg/mL, 0.05 µg·kg?1·min?1) After Spinal-Epidural Anesthesia
Bolus Norepinephrine group:Intermittent Intravenous Bolus Injection of Norepinephrine Solution (4 µg/mL) Based on Patients' Blood Pressure After Neuraxial Anesthesia

Sponsors

Shanghai General Hospital Jiuquan Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Aged 18–45 years; singleton gestation >=36 weeks,; scheduled for elective cesarean section under combined spinal-epidural anesthesia (CSEA); American Society of Anesthesiologists (ASA) physical status classification Grade ?–?; willing to participate in this trial and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Presence of contraindications related to neuraxial anesthesia; (2) Allergy to any drug used in this study; (3) Recent use of vasoactive drugs; (4) Complicated with hypertension or diabetes mellitus; (5) Known fetal malformation or occurrence of fetal distress; (6) Complicated with varicose veins or a history of bleeding; (7) Complicated with liver or renal impairment; (8) Inability or refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Nausea and Vomiting;

Secondary

MeasureTime frame
Hypotension;Hypertension;bradycardia;respiratory depression;Overall stability of heart rate (HR) and systolic arterial blood pressure (SBP) relative to baseline values ;Umbilical arterial blood gas analysis values;1-minute Apgar scores of the fetus after delivery;5-minute Apgar scores of the fetus after delivery;Dosage of norepinephrine;Dosage of additional local anesthetics for epidural anesthesia;Dosage of atropine;Urine output;Incidence of surgical adverse reactions: traction response, chest tightness, shoulder pain, etc;Incidence of anesthetic adverse reactions: headache, hypothermia;Operation time;time from neuraxial anesthesia to fetal delivery;

Countries

China

Contacts

Public ContactYuan Yuan

Shanghai General Hospital Jiuquan Hospital

yuanyuan_186@126.com+86 156 2227 7149

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026